This document introduces the ICH Q3D guideline and training material briefing.
This Japanese training briefing presents the ICH Q3D guideline and training material on other routes of administration, dated March 11, 2016, prepared by the Japan Pharmaceutical Manufacturers Association ICH project committee. It is example material prepared by the Q3D Implementation Working Group and is not official policy or guidance.
The document explains the general approach for calculating route-specific acceptable levels (AL) for elemental impurities, starting from the oral preparation permitted daily exposure (PDE). It covers the basic policy for route-dependent safety assessment, bioavailability and correction factors, exposure duration and retention time, considerations for certain dermal and ophthalmic preparations, and worked examples including eye drops for dry eye. This manual is written in Japanese.
The permitted daily exposure (PDE) for oral preparations shown in Appendix 3 is considered.
It can be expressed by concentration (ug/g or ppm) and by dose (ug/day or ug/amount).
The retention time in the eye is less than 1 hour.